Document is current
Any future updates will be listed below
-
Authors
Godinez-Macias, Karla P.
Chen, Daisy
Wallis, J. Lincoln
Siegel, Miles G.
Adam, Anna
Bopp, Selina
Carolino, Krypton
Coulson, Lauren B.
Durst, Greg
Thathy, Vandana
Esherick, Lisl
Farringer, Madeline A.
Flannery, Erika L.
Forte, Barbara
Liu, Tiqing
Godoy Magalhaes, Luma
Gupta, Anil K.
Istvan, Eva S.
Jiang, Tiantian
Kumpornsin, Krittikorn
Lobb, Karen
McLean, Kyle J.
Moura, Igor M. R.
Okombo, John
Payne, N. Connor
Plater, Andrew
Rao, Srinivasa P. S.
Siqueira-Neto, Jair L.
Somsen, Bente A.
Summers, Robert L.
Zhang, Rumin
Gilson, Michael K.
Gamo, Francisco-Javier
Campo, Brice
Baragaña, Beatriz
Duffy, James
Gilbert, Ian H.
Lukens, Amanda K.
Dechering, Koen J.
Niles, Jacquin C.
McNamara, Case W.
Cheng, Xiu
Birkholtz, Lyn-Marie
Bronkhorst, Alfred W.
Fidock, David A.
Wirth, Dyann F.
Goldberg, Daniel E.
Lee, Marcus C. S.
Winzeler, Elizabeth A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 GM139790, R01 AI172066, R01 AI172066)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2023/10879-1)
Bill and Melinda Gates Foundation (INV-033538, INV-045096, INV-033538)
National Institutes of Health,United States (R01 AI52533)
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 22 January 2025
First Online: 4 March 2025
Competing interests
: M.K.G. has an equity interest in and is a cofounder and scientific advisor of VeraChem LLC, and is on the SABs of InCerebro Inc, Denovicon Therapeutics, and Beren Therapeutics. E.L.F. and S.P.S.R. are employees of Novartis Pharma AG and may own shares in Novartis Pharma AG. K.D. holds stock in TropIQ Health Sciences. The remaining authors declare no competing interests.
